Every Form 4 that PARKERVISION INC (PRKR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PRKR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRKR filings page.
ParkerVision reported an insider equity award to its leader. On January 22, 2026, Chief Executive Officer and director Jeffrey Parker received a grant of a performance-based nonqualified stock option covering 8,000,000 shares of ParkerVision common stock with an exercise price of $0.24 per share. The option vests based on specified performance conditions that are measured quarterly over a five-year performance period. Any portion of the option that has not vested by January 22, 2031 will be cancelled. After this grant, Parker is shown as directly holding 8,000,000 derivative securities related to this option.
ParkerVision Inc. Chief Financial Officer Cynthia L. French reported the grant of two nonqualified stock option awards. On January 22, 2026, she was awarded 500,000 nonqualified stock options with an exercise price of $0.24 per share, exercisable in four equal bi-annual installments beginning July 22, 2026. She also received 500,000 performance-based nonqualified stock options at an exercise price of $0.24 per share, which vest based on specified performance conditions measured quarterly over a five-year period. Any portion of this performance-based grant that does not vest by January 22, 2031 will be cancelled.
ParkerVision Inc. director Paul A. Rosenbaum received a stock option grant as part of his 2026 Board compensation. On January 22, 2026, he was awarded an option to purchase 370,000 shares of ParkerVision common stock at $0.24 per share, held directly. This option represents his beneficial ownership of 370,000 derivative securities after the transaction.
The option vests in two equal installments, with half vesting on July 22, 2026 and the remaining half on January 22, 2027, aligning the award with continued Board service over that period.
ParkerVision Inc. director Lewis H. Titterton Jr. reported an award of stock options as compensation for 2026 Board service. On January 22, 2026, he received an option to purchase 370,000 shares of common stock at an exercise price of $0.24 per share. Following this grant, he beneficially owns 370,000 derivative securities directly. The option vests in two equal installments on July 22, 2026 and January 22, 2027, aligning vesting with his Board service period.
ParkerVision Inc. reported a stock option award to director Robert Greene Sterne. On January 22, 2026, he received an option to purchase 370,000 shares of common stock at an exercise price of $0.24 per share, expiring January 22, 2031.
The option is compensation for 2026 Board service and vests in two equal installments on July 22, 2026 and January 22, 2027. After this grant, Sterne beneficially owns 370,000 derivative securities directly.
ParkerVision, Inc. (PRKR) reported an insider share purchase by a company director. The reporting person acquired 4,761,905 shares of common stock at $0.21 per share for an aggregate purchase price of $1,000,000. The price matched the last sale price of ParkerVision common stock on November 14, 2025, and the transaction closed on November 17, 2025. Following this purchase, the director beneficially owns 8,578,170 shares directly. The purchase was executed under an existing shelf registration statement on Form S-3 that was declared effective on May 28, 2025, and was reviewed and approved by the disinterested members of the board in accordance with Florida corporate law.
Director Lewis H. Titterton reported option grants and subsequent exercises that change his holdings in Parkervision Inc. (PRKR). On 10/07/2025 he reported two nonqualified stock option transactions: 525,000 options at an exercise price of $0.18 and 275,000 options at $0.20. The first option series vests in equal quarterly installments beginning 01/27/2024; the second vested in four equal quarterly increments beginning 05/01/2024 and became fully exercisable on 02/01/2025. Following these reported transactions, Mr. Titterton beneficially owns 3,816,265 shares of common stock. The filings show the options underlie 525,000 and 275,000 common shares respectively, with the $0.18 options expiring 11/18/2028.